BOSTON, January 7, 2018 – PAREXEL Worldwide Company, a number one innovator of worldwide biopharmaceutical companies, at this time launched a brand new, devoted division to help rising biotech corporations in reaching their drug growth and commercialization objectives rapidly and cost-effectively. PAREXEL Biotech builds on the Firm’s heritage of medical, regulatory, industrial and know-how experience with enhanced strategic consulting and asset growth capabilities, providing a brand new Biotech-focused workforce and organizational construction for purchasers. Led by James Anthony, International Head of Biotech, and Graciela Racaro, International Head of Biotech Operations, the division will assist rising corporations reduce complexity, cut back prices, and speed up timelines. “As we speak’s rising biotech corporations have an more and more essential position in figuring out and growing new medicines that actually function the modern arm of the trade,” stated James Anthony. “Nevertheless, these corporations face vital pressures and challenges when it comes to timelines, assets and funding to succeed.” Graciela Racaro added, “We stay up for combining PAREXEL’s experience and international infrastructure with an agile and environment friendly supply mannequin that’s aligned to this particular phase, enabling rising biotech corporations to concentrate on their core capabilities and attain their strategic objectives.”PAREXEL Biotech takes a consultative method to develop tailor-made methods that assist corporations obtain their goals all through the journey from discovery, proof of idea, growth, registration and in the end commercialization, with companies that embody:International regulatory consulting, with greater than 50 former regulators from around the globe and greater than 1,000 regulatory consultants on workers;Technique consulting led by Well being Advances, a boutique consultancy with greater than 26 years of expertise within the biotech sector;China Advisory Providers to assist corporations take part within the nation’s rising, but advanced market alternative;Quantitative Scientific Improvement and Genomic Medication Providers to optimize medical success and maximize product worth;Affected person recruitment companies confirmed traditionally to supply 22 p.c sooner enrollment from first topic randomized to final topic randomized[1]Trial execution companies, with completion charges traditionally four p.c sooner than trade averages from ultimate protocol out there to Scientific Examine Report accepted[2];Actual World Proof packages knowledgeable by and related to biotech stakeholder views and necessities.“PAREXEL has been working to help biotech corporations throughout the globe with medical analysis companies and regulatory consulting for a few years, efficiently undertaking greater than 650 tasks on this house and growing a deep understanding of the wants of those corporations,” stated Peyton Howell, Chief Business and Technique Officer for PAREXEL. “To construct on our dedication to biotech success, we’ve grown our capabilities to incorporate administration and technique consulting, pipeline growth, worth substantiation and proof vetting. This allows us to supply expertise, experience and partnership all through the biotech journey, and produce even better worth to this sector.” For extra info and insights from PAREXEL Biotech go to [1] Supply: KMR Group – Scientific Group 2015-2017[2] Supply: KMR Group – Scientific Group 2015-2017About PAREXEL Worldwide PAREXEL Worldwide Company is a number one innovator of worldwide biopharmaceutical companies. We simplify our purchasers’ journey of reworking scientific discoveries into new medical therapies for sufferers with high-quality Part I-IV medical analysis, regulatory, consulting and market entry companies. PAREXEL develops breakthrough improvements and options by leveraging its complete therapeutic, technical and practical experience, in additional than 100 international locations around the globe. For extra info, go to our web site and comply with us on LinkedIn and Twitter.PAREXEL is a registered trademark of PAREXEL Worldwide Company. All different emblems are the property of their respective homeowners. # # #PAREXEL Contacts:Media:Wendy Ryan Tel.: +1 781-434-5104E-mail: [email protected] Kathryn McMahon Arrigg, PAN Communications Tel.: +1 617-502-4300E-mail: [email protected]